Found 174 news articles for inflammation

Order by most

Recent Relevant

  • Australia’s largest group of inflammation researchers

    …world race to deliver a COVID-19 vaccine, Hudson Institute researchers are using their world-leading inflammation research expertise to develop treatments to mitigate the deadly inflammation caused by SARS-CoV-2. COVID-19, hyper-inflammation……  Read more

    The nuclei of mouse fibroblasts treated with a low dose of a chemotherapy drug for 2 days. The vesicles contain damaged DNA (revealed by the green and red overlay).

  • COVID-19 treatment clinical trial underway

    …active ingredient in the anti-cancer drug Veyonda, idronoxil, could block the production of several pro-inflammatory proteins, known as cytokines. These proteins are involved in the ‘cytokine storm’ or hyper-inflammation that……  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute

  • The Ron Evans AM Fellowship

    …in bowel inflammation and cancer. Over the past five years, Dr Dannappel has published his work on mechanisms of bowel inflammation in top scientific journals, including Immunity, Molecular Cell and……  Read more

    Dr Marius Dannappel and Dr Madara Ratnadiwakara, post-doctoral scientists at Hudson Institute

  • Umbilical cord blood could improve brain injury in babies

    …which affects muscle tone, movement and motor skills. Nearly half of all infants treated with the current best-practice therapy of whole-body cooling, to reduce inflammation and interrupt brain injury, will……  Read more

    Tayla Penny and Courtney McDonald from The Ritchie Centre at Hudson Institute

  • Funding boost to develop lung treatment for premature babies

    …amniotic sac which surrounds a baby during pregnancy. They have stem cell-like properties and can grow into many cell types. Most importantly, they have potent effects on inflammation and tissue……  Read more

    Associate Professor Rebecca Lim from the Amnion Cell Biology Research Group at Hudson Institute

  • Sepsis nearly took Dr Michael Gantier’s life. Now he studies it.

    …for life-threatening COVID-19 symptoms, which includes acute respiratory distress syndrome and sepsis. These are reactions caused by excessive inflammation – part of the body’s own natural immune response to infection……  Read more

    Dr Michael GantierDr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute

  • Stem cell therapies receive MRFF funding

    Associate Professor Rebecca Lim has been awarded more than $470,000 from the Australian Government’s Medical Research Future Fund to pursue research into stem cell therapies for liver disease. A/Prof Lim……  Read more

    Associate Professor Rebecca Lim from the Amnion Cell Biology Research Group at Hudson Institute

  • Crohn’s disease diagnosis impacts future health

    …of Gastroenterology and Hepatology, involved 96 pediatric patients at Royal London Hospital and Massachusetts General Hospital who underwent surgery. It found those with abnormal gastroscopy results—upper gastrointestinal tract inflammation—were associated……  Read more

    Edward Giles from the Regulation of Interferon and Innate Signalling Research Group at Hudson Institute

  • $2.2 million awarded to tackle rare ovarian cancer

    …Inflammation and Immunity Theme Funders | Medical Research Future Fund Emerging Priorities and Consumer Driven Research Initiative – 2019 Ovarian Cancer Research Grant Diseases we research Ovarian cancer | Learn……  Read more

    Professor Peter Fuller AM and Dr Simon at the Hudson Institute of Medical Research

  • Cell therapies trial planned for COVID-19

    …many cell types. Most importantly, they have potent effects on inflammation and tissue damage. A/Prof Lim and Professor Euan Wallace are developing a clinical trial to investigate whether these cells……  Read more